PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates

被引:61
作者
Kamata, Shotaro [1 ]
Oyama, Takuji [2 ]
Saito, Kenta [1 ]
Honda, Akihiro [1 ]
Yamamoto, Yume [1 ]
Suda, Keisuke [1 ]
Ishikawa, Ryo [1 ]
Itoh, Toshimasa [3 ]
Watanabe, Yasuo [4 ]
Shibata, Takahiro [5 ]
Uchida, Koji [6 ]
Suematsu, Makoto [7 ]
Ishii, Isao [1 ]
机构
[1] Showa Pharmaceut Univ, Lab Hlth Chem, Machida, Tokyo 1948543, Japan
[2] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi 4008510, Japan
[3] Showa Pharmaceut Univ, Lab Drug Design & Med Chem, Machida, Tokyo 1948543, Japan
[4] Showa Pharmaceut Univ, Lab Pharmacol, Machida, Tokyo 1948543, Japan
[5] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan
[6] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan
[7] Keio Univ, Dept Biochem, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan
基金
日本科学技术振兴机构;
关键词
PROLIFERATOR-ACTIVATED RECEPTORS; CRYSTALLIZATION; RECOGNITION; SELECTIVITY;
D O I
10.1016/j.isci.2020.101727
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Most triacylglycerol-lowering fibrates have been developed in the 1960s-1980s before their molecular target, peroxisome proliferator-activated receptor alpha (PPAR alpha), was identified. Twenty-one ligand-bound PPAR alpha structures have been deposited in the Protein Data Bank since 2001; however, binding modes of fibrates and physiological ligands remain unknown. Here we showthirty-four X-ray crystallographic structures of the PPAR alpha ligand-binding domain, which are composed of a "Center'' and four "Arm'' regions, in complexes with five endogenous fatty acids, sixfibrates in clinical use, and six synthetic PPAR alpha agonists. High-resolution structural analyses, in combination with coactivator recruitment and thermostability assays, demonstrate that stearic and palmitic acids are presumably physiological ligands; coordination to ArmIII is important for high PPAR alpha potency/selectivity of pemafibrate and GW7647; and agonistic activities of four fibrates are enhanced by the partial agonist GW9662. These results renew our understanding of PPAR alpha ligand recognition andcontribute to the molecular design of next-generation PPAR-targeted drugs.
引用
收藏
页数:28
相关论文
共 42 条
[31]   Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ [J].
Nolte, RT ;
Wisely, GB ;
Westin, S ;
Cobb, JE ;
Lambert, MH ;
Kurokawa, R ;
Rosenfeld, MG ;
Willson, TM ;
Glass, CK ;
Milburn, MV .
NATURE, 1998, 395 (6698) :137-143
[32]   Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures [J].
Oyama, Takuji ;
Toyota, Kenji ;
Waku, Tsuyoshi ;
Hirakawa, Yuko ;
Nagasawa, Naoko ;
Kasuga, Jun-ichi ;
Hashimoto, Yuichi ;
Miyachi, Hiroyuki ;
Morikawa, Kosuke .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2009, 65 :786-795
[33]   UCSF chimera - A visualization system for exploratory research and analysis [J].
Pettersen, EF ;
Goddard, TD ;
Huang, CC ;
Couch, GS ;
Greenblatt, DM ;
Meng, EC ;
Ferrin, TE .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (13) :1605-1612
[34]   Peroxisome Proliferator-Activated Receptor Alpha Target Genes [J].
Rakhshandehroo, Maryam ;
Knoch, Bianca ;
Muller, Michael ;
Kersten, Sander .
PPAR RESEARCH, 2010, 2010
[35]  
WHO, 2017, CARD DIES
[36]   Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ [J].
Wu, Chyuan-Chuan ;
Baiga, Thomas J. ;
Downes, Michael ;
La Clair, James J. ;
Atkins, Annette R. ;
Richard, Stephane B. ;
Fan, Weiwei ;
Stockley-Noel, Theresa A. ;
Bowman, Marianne E. ;
Noel, Joseph P. ;
Evans, Ronald M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (13) :E2563-E2570
[37]   Molecular recognition of fatty acids by peroxisome proliferator-activated receptors [J].
Xu, HE ;
Lambert, MH ;
Montana, VG ;
Parks, DJ ;
Blanchard, SG ;
Brown, PJ ;
Sternbach, DD ;
Lehmann, JM ;
Wisely, GB ;
Willson, TM ;
Kliewer, SA ;
Milburn, MV .
MOLECULAR CELL, 1999, 3 (03) :397-403
[38]   Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors [J].
Xu, HE ;
Lambert, MH ;
Montana, VG ;
Plunket, KD ;
Moore, LB ;
Collins, JB ;
Oplinger, JA ;
Kliewer, SA ;
Gampe, RT ;
McKee, DD ;
Moore, JT ;
Willson, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13919-13924
[39]  
Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a
[40]  
YAMASHITA S, 2020, INT J MOL SCI, V22, DOI DOI 10.1007/S11883-020-0823-5